Atalaya Capital Management’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Atalaya Capital Management’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-500,000	Closed	-$5.12M	–	226
2023 Q1	$5.12M	Hold	500,000	–	–	1.63%	17
2022 Q4	$5.04M	Hold	500,000	–	–	0.9%	31
2022 Q3	$4.93M	Hold	500,000	–	–	0.67%	44
2022 Q2	$4.87M	Hold	500,000	–	–	0.58%	57
2022 Q1	$4.88M	Hold	500,000	–	–	0.52%	57
2021 Q4	$4.92M	Hold	500,000	–	–	0.48%	53
2021 Q3	$4.92M	Buy	+500,000	New	+$4.88M	0.75%	34

Atalaya Capital Management's ORIA Position: Q2 2023 in Review

Atalaya Capital Management sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 500,000 shares — an estimated $5.12M sold.

Atalaya Capital Management first reported a position in ORIA in Q3 2021 and held it in 7 quarters. The position peaked at $5.12M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Atalaya Capital Management reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Atalaya Capital Management sold 500,000 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $5.12M.
Atalaya Capital Management first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2021 and held it in 7 quarters.
Atalaya Capital Management's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $5.12M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Atalaya Capital Management's 13F filing for Q2 2023, filed 9 Aug 2023.